Life sciences companies face the daunting challenge of research, discovery and reinvention on a daily basis. The industry is ever changing and the challenges its leaders face are complex and multifaceted. For companies specializing in the biotechnology, pharmaceutical and medical device and technology sectors, it is critical that their advisors understand their business, not just from a financial perspective, but from a technical and a regulatory perspective as well. Our partners have worked with closely with many of the companies that have shaped this industry for over a decade. We understand the industry, the regulatory environment and the challenges our clients face.
Key life sciences industry sectors served include the following.
Relatively speaking, the biotechnology industry is quite young at 30 years of age. However, with a market size exceeding $100 billion annually, it is anything but small. The industry is defined less by its products and more by the technologies employed by companies operating within the industry. These technologies are characterized by their use of organisms, cells, or biological compounds to make products that carry desired traits. The application of these technologies spans a broad range of products as diverse as pharmaceuticals and cleaning detergents.
Over the past decade, our partners have served many of the largest biotechnology companies in the world on a wide variety of projects for financial reporting, tax planning and compliance, and strategic planning purposes. We have extensive expertise valuing both approved and pipeline compounds, intellectual property, licensing deals and partnerships, platform technologies, and R&D equipment and assays.
The pharmaceutical industry is currently a $725 billion business globally, dominated by a small number of large companies that can trace their lineage back to the late 19th and early 20th centuries. The industry’s primary focus is upon the development of novel drugs for medicinal purposes, but the supply chain has many elements, including: drug manufacturing, drug distribution, retail pharmacies, hospitals and other customer suppliers and the variety of pharmacy benefit managers that manage reimbursement. Adding to the already complex nature of the industry is the fact that it is subject to a variety of laws and regulations regarding the patenting, testing and marketing of drugs, many of which have a significant impact on value.
Over the past decade, our partners have served many of the most prominent pharmaceutical companies in the world on a wide variety of projects for financial reporting, tax planning and compliance, and strategic planning purposes. We have extensive expertise valuing both generic and prescription drug companies and their assets and technologies.
Medical Devices and Technologies